Daniel M. Schmitt has served as Actuate Therapeutics' President and Chief Executive Officer since March 2015 and as a director since April 2015. He brings more than 30 years of pharmaceutical and biotechnology experience across operations management, new product development and business development, and has led high-value licensing, acquisition and development transactions. He previously served as Chief Operating Officer of Genus Oncology, LLC from 2009 to 2014; Senior Vice President, Licensing and Commercial Development of Immtech Pharmaceuticals, Inc. from 2004 to 2009; and General Manager, Academic and Government Institution Markets of First Genetic Trust from 2001 to 2004, and earlier held positions with G.D. Searle, ILEX Oncology, Fujisawa USA and Burroughs Wellcome. He is a founding member of Chicago Innovation Mentors and earned an M.B.A. and a B.S. in Chemistry from West Virginia University.